Colleen Dorsey

954 total citations
6 papers, 11 citations indexed

About

Colleen Dorsey is a scholar working on Genetics, Pathology and Forensic Medicine and Management Information Systems. According to data from OpenAlex, Colleen Dorsey has authored 6 papers receiving a total of 11 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 1 paper in Management Information Systems. Recurrent topics in Colleen Dorsey's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers) and Big Data and Business Intelligence (1 paper). Colleen Dorsey is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers) and Big Data and Business Intelligence (1 paper). Colleen Dorsey collaborates with scholars based in United States, Canada and Spain. Colleen Dorsey's co-authors include Anthony R. Mato, Molly Fanning, Kaitlin Kennard, T. J. O’Brien, Maryam Sarraf Yazdy, Suman Kambhampati, Chhavi Chauhan, Mazyar Shadman, Paul M. Barr and John M. Pagel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hematological Oncology.

In The Last Decade

Colleen Dorsey

6 papers receiving 11 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colleen Dorsey United States	2	8	7	4	2	2	6	11
Christine D Crider South Africa	1	6 0.8×	5 0.7×	4 1.0×			2	6
Doriane Cavalieri France	3	6 0.8×	4 0.6×	6 1.5×	2 1.0×		5	13
I. Serriello Italy	3	12 1.5×	8 1.1×	5 1.3×	3 1.5×	1 0.5×	5	20
Neil McIver‐Brown United Kingdom	2	7 0.9×	8 1.1×	5 1.3×	1 0.5×		3	11
Ilda Murillo Spain	2	8 1.0×	3 0.4×	6 1.5×	2 1.0×		2	9
Robéria Mendonça de Pontes Brazil	3	8 1.0×	3 0.4×	7 1.8×	3 1.5×	2 1.0×	6	11
Dureshahwar Jawaid United States	3	11 1.4×	8 1.1×	8 2.0×		1 0.5×	7	11
Weihong Chase United States	2	9 1.1×	4 0.6×	4 1.0×	6 3.0×	1 0.5×	3	16
Vera Stoeva Bulgaria	3	8 1.0×	2 0.3×	8 2.0×	2 1.0×		8	15
James Laffan United Kingdom	2	5 0.6×	3 0.4×	2 0.5×		1 0.5×	3	14

Countries citing papers authored by Colleen Dorsey

Since Specialization

Citations

This map shows the geographic impact of Colleen Dorsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Dorsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Dorsey more than expected).

Fields of papers citing papers by Colleen Dorsey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Dorsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Dorsey. The network helps show where Colleen Dorsey may publish in the future.

Co-authorship network of co-authors of Colleen Dorsey

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Dorsey. A scholar is included among the top collaborators of Colleen Dorsey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Dorsey. Colleen Dorsey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Dorsey, Colleen, et al.. (2022). Case Study: The Distilling of a Biased Algorithmic Decision System through a Business Lens. SSRN Electronic Journal. 1 indexed citations

2.

Dorsey, Colleen. (2020). Ethics in artificial intelligence and machine learning: The importance of opening the dialogue for new processes at your organisation. 3(3). 233–233. 1 indexed citations

3.

Yazdy, Maryam Sarraf, Lindsey E. Roeker, Mayur Narkhede, et al.. (2019). HYPERTENSION (HTN) IN PATIENTS (PTS) TREATED WITH IBRUTINIB (IBR) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). Hematological Oncology. 37(S2). 212–213. 1 indexed citations

4.

Ujjani, Chaitra S., Lindsey E. Roeker, Mazyar Shadman, et al.. (2019). Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL Patients. Blood. 134(Supplement_1). 1758–1758. 1 indexed citations

5.

Mato, Anthony R., Stephen J. Schuster, Nicole Lamanna, et al.. (2018). A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy.. Journal of Clinical Oncology. 36(15_suppl). 7530–7530. 6 indexed citations

6.

Timlin, Colleen, Rahul Banerjee, Christina Howlett, et al.. (2016). Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study.. Journal of Clinical Oncology. 34(15_suppl). 7529–7529. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact